LDN Video Interviews and Presentations

Radio Show interviews, and Presentations from the LDN 2013, 2014, 2016, 2017, 2018 and 2019 Conferences

They are also on our    Vimeo Channel    and    YouTube Channel

Pharmacist Neema Yazdanpanah, LDN Radio Show 07 July 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Neema Yazdanpanah shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Neema Yazdanpanah has been a compounding Pharmacist for only a year, but is very knowledgeable and extremely enthusiastic about the effectiveness of Low Dose Naltrexone. He has done extensive study of LDN because it has been helpful to his patients with numerous autoimmune conditions. 

He did a survey of 62 patients for 3 months regarding side effects, effectiveness, and satisfaction of taking LDN. The average score was 9.12 on a 1-10 scale on effectiveness. Only 18% experienced minimal side effects which subsided after a week or two. This survey will be available on the LDN Research Trust site soon.

This is a summary of Dr Neema Yazdanpanah’s interview. Please listen to the rest of Dr Yazdanpanah’s story by clicking on the video above.

Dr John Robinson, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. John Robinson is from Scottsdale Arizona in the US. He first heard about low dose naltrexone (LDN) 5 years prior, as a mention by colleagues, and did a bit of research on it. As his focus on thyroid hormone replacement grew, and having patients with Hashimoto’s not doing as well as he would like, he looked again into LDN and has had great results in particular in patients with Hashimoto’s and Graves’ disease, and their clinic The Hormone Zone, in Scottsdale.

Dr. Robinson pointed out that once on LDN, some patients might not need as much thyroid hormone, although he has not seen that, and ensures his patients have adequate amounts of thyroid hormone. They watch lab markers closely, for markers in Hashimoto’s to go down, and to catch the flares. Key markers are anti-TPO (anti-thyroid peroxidase), and anti-TG (anti-thyroglobulin). These two are necessary elements to help with thyroid hormone synthesis, but in an autoimmune condition like Hashimoto’s or Graves’ disease, the thyroid is attacked, including those two enzymes or protein, and can be measured in the blood. So, for a patient with suspected thyroid disease and elevated markers, the first offense against that is LDN, which typically results in a decrease overall in the markers. At his office, one goal is to collect this type of data and start showing that patients are improving.

Generally, patients are started on 1.5 mg, a very low dose to minimize any side effects; increase to 3 mg LDN the next week, and the following week increase to 4.5 mg and stay there. Some patients report vivid dreams or nausea for the first week or so, and sometimes this results in lowering the dose for a while, or changing to taking LDN in the morning. Patients report improvement relatively quickly, usually within a couple of weeks. Because of the temporary endorphin suppression and rebound that occurs at night, it’s better to take LDN at bedtime.

In addition to LDN, Dr. Robinson also advises on other things, such as nutrition, dietary factors affecting Hashimoto’s, other hormone replacement therapy options for estrogen or testosterone, and so on, so at times it’s challenging to precisely figure out what’s happening.  But people where LDN was added after those other treatments are doing amazingly well. Some have a better sense of well-being, probably related to the endorphin release from LDN. And we see the markers like anti-TPO and anti-TG change.

Dr. Robinson had a patient on LDN for about 6 months and doing well, and her anti-TPO was down. On her recent visit her anti-TPO jumped to over 4,000, when they want to see the anti-TPO at less than 60. As it turned out she had a happy holiday season in terms of alcohol, and eating – particularly gluten and bread – she knew she had allergies to. A point is that any treatment has to be considered within a comprehensive approach towards health.  In this case, her Hashimoto’s was triggered by her gut dysbiosis or allergies from the diet.

Dr. Robinson thinks most people have some level of issue with gluten, or some other allergens, and attributes it to the type of wheat we use. They should stay away from it. At The Hormone Zone, there is a focus on the ketogenic diet for autoimmune conditions. This diet keeps carbohydrates around 5% - which pretty much keeps you away from gluten, because foods like bread tend to have a higher carbohydrate level.

The website for The Hormone Zone is https://hormone-zone.com/.   Phone 480-613-8357. They are located very close to the Scottsdale Arizona airport, not far from the Phoenix airport. If people do an initial in-person consultation, they can do follow-up by telephone. And if the treatment includes LDN, he is more than happy to prescribe this very effective and inexpensive medication.

Summary from Dr. John Robinson, listen to the video for the show.

Keywords: LDN, low dose naltrexone, thyroid, hormone, Hashimoto’s, Graves’, markers, anti-TPO, anti-TG, gluten, ketogenic diet, gut dysbiosis, autoimmune

Any questions or comments you may have, please contact us. I look forward to hearing from you. 

Dr John Kim, LDN Radio Show 07 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today we're joined by Dr John Kim. Thank you for joining us, John.

Dr John Kim: Well, thank you for the invitation, Linda,

Linda Elsegood: For those people that haven't heard you on our Vimeo channel, would you like to tell us what it is you actually do in medicine?

Dr John Kim: I'm actually in-between transition, as some people may know. For the last ten years, I've been working in Georgia where 50% of my practice is in pain management, and then the other 50% is solving complex medical puzzles; especially autoimmune conditions. I actually discovered LDN as a part of the second part of the practice, and the second part of the practice actually came about because I had wonderful techniques to help patients with chronic pain, except for patients with autoimmune disease pain. Those pains just were harder and tougher, and I had to change my paradigm and look for other tools other than what I had, and kind of open the door through LDN to treat the whole bunch of other conditions, especially autoimmune conditions with a great deal of success.

Linda Elsegood: Would you like to tell us what it is you have trained in?

Dr John Kim: So the original training in medicine began with family medicine, and I chose that because it was the most holistic of all areas. But I wanted to train more, so I actually changed my career to a speciality; to preventative medicine, and then from there I learned medical acupuncture, and then went on for a fellowship in integrative medicine with Dr Andrew Weil as a residential fellow. That kind of sums up my traditional training, but I've also done extensive basic science research in biochemistry and pharmacology.

Linda Elsegood: What would you say the outcomes have been for the patients that you have prescribed LDN for?

Dr John Kim: LDN for me hits even closer because the LDN originally was brought to me by one of my favourite patients. I'm not supposed to have favourite patient, but the patient is a favourite because she one day said, ‘Hey,I have this condition called Hashimoto's thyroiditis, and the prognosis is really depressing. I get to take medication and as Hashimoto's thyroiditis destroys more of my thyroid I get to take more and more, and you never get off it’. And she said, ‘I found something interesting called low dose naltrexone, and would you please do research?’ And I said ‘sure’ and when I did research about it, that was about ten years ago, there were fewer research articles, but even then, it really looked like the risk-benefit profile, meaning how much risk is there and how much benefit is there, was very, very limited; small, and the benefits sound so incredible. So, I prescribed the medication and what happened was that her disease went into remission, full remission, and did not require any further use of hormone treatment. Then what had happened was that within several years she got pregnant and, retained her baby, because before she was having issues with, I think miscarriage, and then she gave birth. And then after the birth, her disease returned, almost like Graves and we again used low dose naltrexone very successfully and helped the illness to go into remission as well. 

Linda Elsegood: And did she take the LDN throughout her pregnancy?

Dr John Kim: Yes. LDN through pregnancy is a very interesting topic and I had them talk to their doctor, but you know, part of the acupuncture practice I have, a small part of it is fertility. And I've noticed that LDN helps patients to get pregnant. For those I think who have issues with their ability to get pregnant it’s often coming from an autoimmune condition, and I think that LDN can reverse that.

Then I've seen LDN reverse endometriosis, and again, I think that a lot of the illnesses that we have seen have an autoimmune basis. We don't use the word autoimmune, what I like to use is the dysfunctional or stunted immune system. The immune system is no longer being intelligent, and I think the LDN corrects it.

That's why I think that LDN is such an interesting drug because LDN seems to be what we call an adaptogen, which means that it brings a system into balance. So if it's too much, it brings it down. If it's too little, it kicks it up. And I think that's how LDN works for from everything. From autoimmune diseases to HIV, to cancer.

And LDN, I think is like almost a class of its own, because it does so many nifty, therapeutic actions with some limited side effects. 

Linda Elsegood: What side effects have you noticed with your patients?

Dr John Kim: There are at least two people that I've seen that had a severely depleted state of endorphin.

They’d been ill for a long, long, long time, and their resilience is very, very limited. And for those people, I've noticed that even with one microgram of low dose naltrexone, they have a hard time taking it. And. If there was a homoeopathic pharmacy, I wondered if they could make a nanogram dosing of low dose naltrexone for these people, but these people are few and far between.

For most of the other people who have side effects, they find it easier to handle. Like some people, instead of it helping them to sleep, it has the opposite effect. So, if that's the case, it's pretty simple, they just take it at dinner time or in certain cases, I just tell them to take it with lunch or even at breakfast time.

Linda Elsegood: Well, we did have a question, which fits in quite nicely with what you're saying, and it's from Deb, and she has her own thyroid group with LDN, and she says, ‘have you seen a patient with a genuine allergic reaction, not just a side effect on  1.5 milligrams of LDN?’

Dr John Kim: So I think that the allergic reaction if they're talking about an anaphylactic reaction, that's probably due to the filler, not necessarily to do with LDN. As I said, the two people that I have seen a reaction, even one microgram, those people, I think probably had the reaction that they're describing, which is closer to an allergy, however, I've not seen the typical, what they call anaphylactic or IgE mediated response to naltrexone, and it's theoretically possible, but I just haven't seen it at this point.

Linda Elsegood: We have a lady called Lynn from Australia who has been using LDN for two and a half years for graves' disease in kidney neuropathy, and it’s inactive now, but she does have small, reoccurring, low-grade bladder cancer.

Her naturopath suggested that she should take a test to show nutrients, which would affect the cell line of cancer patients, so she's asking ‘would this test be worth having in regard to bladder cancer and LDN?’

Dr John Kim: I think that's a wonderful question, and it also happens to be a complex question. And the reason why I say this is that the low dose naltrexone effect on cancer, I think that is very beyond theoretical. I think that we are beginning to have case series of studies that would be the basis of one day doing a randomized control trial using LDN to use either as an augmented complementary to the conventional therapy or standalone agent. In terms of the nutrition testing, which is very popular we call this approach ’functional medicine’, within the integrative medicine spear. And in that philosophy of testing everything that you can pass on, or micronutrient testing, or even testing of the agents that are a part of the Krebs cycle, and testing those intermediate, biological functional markers to be useful.

And I think that to be honest with you, that the research just is not yet fully there. Spectracell is one company that will basically test different types of antioxidants and vitamins, and I think that it's a reasonable thing to do for cancer patients.

I would not recommend it for everybody who is in good health, but for cancer patients, if you asked me six months ago, I would say, I'm not sure, but I think that because cancer is such a debilitating and life-threatening illness because the conventional medicines alone don’t have full control over cancer.

Because even with LDN, looking at Dr Biharis’s study, that wasn't a hundred per cent. I mean, he did not get a hundred per cent either. So, I think that we have partial answers, but with cancer, we have room for improvement. I think that some types of micronutrient testing for cancer patients makes sense.

Again, that’s not recommended on a healthy person, but for cancer patients, because the stakes are so high, and because of the latest protocol by Dr Berkson, who combined alpha-lipoic acid with low dose naltrexone to help stage four cancer patients to go into remission.

So, if you look at that, then, all of a sudden what else are we missing? I mean, are there systematic studies? No. So then if there are no systematic studies, then you have to become a study of one. And how do you do that? Just like what the natural path is suggesting. I think that it is reasonable for cancer patients, but unfortunately not for everyone.

I think there's part of us that can be narcissistic and say, I want to test everything on you; genetic markers and nutrients, but I think that moderation is often a good way to go, but with cancer, I think that my answer has changed in the last year; the more I think about it, and the more I read, and the more new studies come out.

Linda Elsegood: Okay, we have a question from Christina, and she says ‘I have postpartum thyroiditis from pregnancy in 2011. My thyroid has never recovered and is very large with hypothyroidism. I do not have Hashimoto's. Should I start off at a very low dose because of my thyroid issues?’

Dr John Kim: So that's the wonderful thing about low dose naltrexone. Like I think I've shared earlier, the patient who introduced me to LDN, in the beginning, had Hashimoto's. But then she had postpartum hypothyroidism and LDN works for both, and some people would think, how can that be?

How can LDN increase the function of the thyroid and also decrease the function of the thyroid? If you look at it as LDN is an adaptogen for the immune system, meaning LDN restores the balance of the immune system, then everything makes sense. It's because the low dose naltrexone can increase the overall balance of the immune system that it can help with hyperthyroidism. It can help with hypothyroidism because the mechanism in both cases is exactly the same. Decrease the abnormalities within the immune system, and it does this it seems through glial cells binding through glial cells to There is a certain type of receptor that is responsible for releasing pro-inflammatory molecules. So, LDN binds to that site and does not allow for the release of inflammatory molecules. So, I think that the answer would be yes for somebody in that area, who is capable and is familiar with using LDN for those circumstances. And the other thing is that in such circumstances, I think aggressive testing makes sense.

So for me, if I had patients like that, I’d keep a very close eye on them, and I would test them even monthly to see what their labs are doing.

Linda Elsegood: Oh, she then goes on to say that she's actually been on LDN 1.5 milligrams and she had to take it every other day in the morning because she got very jittery.

She said she built it up to 1.5 milligrams daily and felt better. But then, after three or four weeks, her symptoms suddenly came on strong. She says, ‘does LDN bring out the disease and make you worse before you get better? Should I increase if I start to feel worse? And how long should I expect to feel worse before I start to feel better?’

Dr John Kim: I think that it's very rare. With my patients, I have seen or heard of those reactions. And I think that in one of the emails you sent me, I think that person had a similar reaction, were that there seemed to be a sudden release of catecholamines, which means molecules like epinephrine norepinephrine get released. And in such cases, you really have no choice but to go slowly, and to utilize incremental increases. I think whenever people have like a complex reaction, I will recommend them to consider having more than the standard use of LDN. I would say, you need to use more of a shotgun approach and utilize multiple assets. And I think that seems to be a good example because she's having a complex reaction; it's not a typical reaction. And so, for that, more diagnosis is needed, to see if there are any kind of issues of catecholamines being higher in her body than they should be. There's a test that they can do over 24 hours of urine collection. They can measure the overall amount of catecholamines in the body, and that indicates other problems that can be present. But if she wants to solve the issue, I think the best thing to do is branch out to other tools, and that's where I really love having more than just one tool. So, for example, I would use the LDN, I would use acupuncture because it also increases endorphins and decreases inflammation. Supplements that can also reduce inflammation, as well as immunotherapy that I talked about and those five things are what I recommend people to try before going to the conventional medications. In some cases, I see that even combining all those is not good enough, and then they have to use number six, which is conventional medications and conventional approaches. I think that it's just important that conventional medicine is not our enemy. It is neither a friend nor an enemy.

It's supposed to be our servant. We don't want it to be a master. We don't want it to be a dictator and create all kinds of problems.

Linda Elsegood: Okay. Well, we'll get ready to go into a break. If anybody out there would like to phone in and ask your questions to Dr John Kim, if you want the numbers, just go to www.ldnradio.org.

Linda Elsegood: Now we will take a call. Hello? Can you hear us?

Caller:  I can hear you, yes. Can you hear me?

Linda Elsegood: Fantastic. I can indeed. Yep.

Caller: Getting that somehow, right. Well, I refer to the guy that Dr John said had had a cancer diagnosis three years ago, bowel cancer. I haven't been using naltrexone yet, and I've had some chemotherapy, but on-base occasions I had Capecitabine to start with, and then I had Fluorouracil, and both of them threw me into A & E, so I've gone off the idea completely of conventional, well, what's it called? Chemotherapy. I'm just looking for alternatives. We've changed our diet. We’ve done all sorts of things and are feeling very positive, but just want to find out from you whether you think that I can be helped by LDN.

Dr John Kim: May I ask you what stage of cancer you were diagnosed with?

Caller: Oh, I think it was one.

Dr John Kim: So, then you are cancer-free at this time?

Caller: No. I had a CT scan a couple of weeks ago in November, and that showed that the tumours that they found, that showed up in April, have actually got bigger on my liver and in my right lung. I did have an operation to remove tumours from my left lung. So, I had the left upper lung removed and also I had about 30% of the liver removed.

Dr John Kim: So, when cancer that starts in one area goes to different areas such as liver and lung, it’s considered metastatic or stage four cancer. So the use of low dose effects for cancer that I've read about and that inspired me to use it actually are twofold. One is the original physician who made it popular or known to use LDN. Dr Bihari used low dose naltrexone for treating cancer very successfully and he had documented it. Now there's a second physician. Dr Berkson, who is in New Mexico, who is utilizing low dose naltrexone and alpha-lipoic acid, and in his case he does injections very successfully. So both parties have written about it. Dr Berkson has published his work. So, right now, all of my patients that have cancer, who come to me, pretty much, I recommend them a protocol of low dose naltrexone as well as alpha-lipoic acid, as well as other supplementation.

Now as for stage four cancer, fighting it just using low dose naltrexone generally, you know, I don't recommend it. I recommend using all the tools that you have because of the grade of the diagnosis. Using all the tools is what I recommend. Now, having said that, Dr Berkson does have documented patients who have used low dose naltrexone, and alpha-lipoic acid and the other protocols that he utilizes.

And my recommendation is to find someone near you who has utilized that protocol to success.

Caller: Wasn’t it Professor Dalgleish in the UK?  He's been fairly active I think in the LDN and cancer field. Have you come across him?

Dr John Kim: There's also Professor Liu, with whom Linda has connected me with. And you are part of the LDN research trust on Facebook, right?

Caller: No, I don’t do Facebook.

Dr Kim John: I'd like to highly recommend you to join. It's a really wonderful community to ask other people, especially in your circumstances. In general, I recommend for patients for fighting cancer for integrative medicine, low dose naltrexone, to use all the tools that make sense to them at their disposal. Because really, in my experience at least with stage four cancer, it's really difficult to make peace with stage four cancer. Cancer wants to grow, continues and there is no 99%, it has to be a hundred per cent because if you leave even 1%, it's alive.

It will double, and double. We call that tumour burden, and after the tumour has grown to a certain size, it puts a tremendous amount of burden in or way.

Linda Elsegood: The next caller now, if not, we won't have a chance to get through the queue.

Caller: Oh, sure.

Linda Elsegood: Okay. Thank you. Thank you for your call.

Caller: Thank you very much, Dr John.

Dr John Kim: Yes sir.

Linda Elsegood: Okay. I think we have another question here that may be cancer. Hello? Hello? Are you there?

Caller:  Hello? Are you talking to me?

Linda Elsegood: Yes, I am.

Caller: Okay. This is still us. No, this one wasn't cancer-related, but I can probably find one if you want.

Linda Elsegood: No, that’s fine.

Caller: This is about mast cell activation disorder, and if Dr Kim has ever prescribed or treated anyone with that condition. Has he prescribed LDN?

Dr John Kim: I have not seen one prescribed as such, but I've seen many patients who have the symptoms of this, and I think mast cell activation disorder is closer to what the physician's call IGE, mediated allergic reaction. You know, the mast cells release histamine, and some of the interesting things about that are the speed at which it can occur. It’s very rapid. In some people, you just have to scratch their skin, and you can see a welt developing very quickly.  Is your symptom like that?

Caller: This is a question and from a group member. Not me personally.

Dr John Kim: The answer is that yes, I have utilized LDN, but the utilization of LDN in such cases is an excellent question. I think LDN is a wonder drug for autoimmune diseases, but I don't think LDN, in many cases, should be utilized alone; like the previous caller wanted to use LDN for stage four cancer.

I think that of course, it can be done, if he can find a physician willing to do it, but I think that the better approach in this case and I’ve had patients with similar symptoms, is that LDN combines wonderfully with another immunotherapy, which is more common in Europe. It's called allergy drops, and what you do is you test the person for offending agents from the environment, as well as food. And mostly if IGE with food IGG can also be included. And the wonderful thing about is once you are armed with information, what things can trigger them, you can utilize allergy drops and LDN together to allow the immune system to be reeducated.

So, I'll give you an example. One patient came to me with a mast cell activation, and hers would begin with eating fruit, whatever kind of fruit, she would just not be able to breathe. And she loved fruit, but for ten years, she couldn't eat fruit. And so, I put her on LDN, and it made her symptoms a little bit better. In a year of allergy drops plus

LDN she was able to eat fruits again, and she has no reaction. So in that case, can you get that reaction just by using allergy drops? I think it's possible, but usually allergy drops alone it takes five years. Whereas in this case, within less than a year with both LDN and allergy drop, we were able to get that rapid reaction.

So, I think that LDN is a wonderful tool. Anytime the immune system is not behaving, if it’s hyperactive or sluggish, I think LDN is a wonderful tool, but I think there is this idea, a temptation almost, to view LDN as a single agent for everything. I think that everything has a tool and for some of the patients that have had severe symptoms, I'm not afraid to use LDN and Montelukast, which is also sold under the name of Singulair, and is a prescription medication, or some of them I ask to take Zyrtec and then the allergy drops. And the wonderful thing about LDN is that it seems to re-educate the immune system, so it's almost like an intelligent approach, and it compliments the allergy drop because that is also an intelligent approach.

Caller: Understood. I guess this question probably has the same answer. I’ll just ask it in a different way. Can LDN work to help histamine inflammation? So, would that basically be the same answer?

Dr John Kim: Well, I think the answer is, I think, that I would be more careful to use histamine because what we’re talking about is that what happens after the mast cells have released histamine. So, in this case, what you're looking for is rapid response. Can LDN be used to stop an anaphylactic reaction? I don't think anyone has done the study, but I don't recommend that clinically. If someone is having an acute reaction, I think the proper response would be either Benadryl shot or Benadryl liquid.

Caller: You use the word inflammation. I don't know if that's different from a reaction.

Dr John Kim: The histamine inflammation is very rapid, and I would say if you're in that rapid phase of inflammation and the answer, I think it's similar when you're having rapid phase reaction of inflammation, I think that you have to use all the tools that are required, including steroids,  in case of histamine reaction, an anti-histamine, and then use LDN long term to get gain control. And we basically create another equation, change the equation because LDN can change the basic equation, but at the time, the house is burning down. You want to use everything. LDN is a wonderful tool to redesign the infrastructure so that the immune system just only has one response, inflammation, inflammation, inflammation. LDN can change that, and it's very interesting, because people who have a reaction, in that situation, often their immune system is actually depleted, so that means they get sick easier.

I tell them that's very similar to police being told by naughty teenagers twenty-four-seven that they can't do their job. Whereas the well-rested, police force can respond to emergency calls quite adequately.

Linda Elsegood: Okay. Yes.

Caller: Thank you.

Linda Elsegood: Okay. We're back. And what I would like you to do now John, is could you answer some of the emails that were sent in, please?

Dr John Kim: Absolutely. I really love the questions from your readers or your Facebook group members. They are just so intelligent and wonderful. One of the questions that I had was from a patient who was diagnosed with pancreatic cancer.

She's taking Tramadol for pain, and clinic basically is agreeable to put her on LDN. I'm sorry her or him. But the thing is that they want the person off Tramadol and the person is asking what do you do? I've often seen this sort of question regarding Tramadol or Ultram, which is a brand name and is basically a form of synthetic opioid that's not a full-on opioid. What I mean by that is that it's got two different activities. Number one is that it does bind to the mu-opioid receptor, but it also works as a serotonin and norepinephrine uptake inhibitor.

And I think that it seems to me that this has multiple answers. So, part of the answer is that if the clinic says no, you can't take LDN and Tramadol together, I would say that the person can explore a herb which is very effective, known as corydalis. Corydalis does not use opioid receptor but has high effectiveness for controlling pain.

That is my go-to herb to control pain. The secondary herb can be something like curcumin, and especially if they can find long-acting curcumin, it can be helpful for controlling pain. Another tool that I find exceptionally well-suited that works in conjunction with low dose naltrexone is what I call neuroanatomical approach to acupuncture and is a new way of using acupuncture using scientific principles. And it works on strengthening the endorphin system and reorganizing the neurological signals that are pain prosthesis. The underlying question to this is, can you combine narcotics and LDN? And I think the answer is yes.

I formulate this from research done using what we call the microdose, dosing of LDN. So instead of using the normal dose, LDN use is 1.5 milligrams to 4.5 milligrams, but in micro-dosing, you use microgram doses. A thousand times less than one milligram would be one microgram, and that, even in my clinical use when people are using narcotic agents, my to-go game is to utilize a microdose gram dosing of LDN, and it seems to actually help patients to get pain relief longer. Then what I do is increase the dose of microgram dosing of LDN to push it up. And then what happens is similar to them not taking the medication you're just doing backwards.

By increasing the inhibitor strength, you're basically taking down the amount of narcotic that is effectively available and just two different approaches. But I think that it's more humane and I'm not convinced, because the effective dose for the naltrexone to overcome narcotics is about 5,200 milligrams anyway.

I don't think adding 1.5 milligrams or five milligrams will make a difference in the majority of people. Now I have to say, that because I know that in literature, there are people who are exquisitely sensitive, that even utilization of anaesthetic during surgery didn't work. They had to use massive amounts, and then at the end of they said, what on earth is going on with you? Why is it that I have to use massive doses on narcotics? They say ‘oh, yeah, I'm taking the LDN’. And so in that case, you know that in those people the LDN, is working so well, or probably what is happening to those people is that their affinity; the LDN attraction to the receptor, is exceptionally stronger than the general population.

But in general, I think that LDN, especially micro-dosing naltrexone or very low dose naltrexone, is safe with utilizing narcotics. I think that was a wonderful question.

Linda Elsegood: Do you have time to answer another one?

Dr John Kim: Oh, yes. Oh, there was another question of RSD or the CR, complex regional pain syndrome. That is a really heartbreaking condition.

‘My neurologist started me on 3 milligrams, then 4 milligrams and then 4.5 milligrams. I had some pain relief for six weeks, but the burning pain has returned to the same level. Do you know? Is there a reason? Is this a typical reaction? Do you agree with my doctor’s opinion that I would get more benefits after five months?’

I think that it's, it's kind of interesting because 1.5 milligrams to 4.5 is like the standard, and that's written in stone, but if you really dig in and do the research, those response studies that were performed on low dose naltrexone was sort of a convention developed over time, accepted by researchers. But I think that there are multiple ways low dose naltrexone works, and one way of course, is that it works through the immune system, and I think that the dosing of 1.5 to 4.5 often works quite well.

However, there's another way that LDN and especially for CRPS and neuropathy that LDN can be helpful is that LDN also works as an anti-inflammatory agent for the central nervous system. What that means is that in that setting, the dosing of LDN is going to be more dose-response curve, what I call linear response.

What that means is that depending on who you are, you will need more than 4.5mg. I had patients who needed six milligrams, and who do very well on 6 milligrams or even 7.5 milligrams, and obviously, I don't start a patient on that. I titrate them. And if you look at the original dose of medicine being 5 milligrams, I think even 9 milligrams is not unreasonable for the minority of people, but I think that rather than waiting five months, what I would do is push the dose to 5 milligrams and then 6 milligrams to see or and 7 milligrams to see if that's helpful. The other part is that CRPPS is a nervous system disorder, so alpha-lipoic acid would be another tool that can be very helpful, also taking a very high dose of fish oil also can be helpful, but taking a high dose of fish oil can result in bleeding episodes or even bruising episodes. So, it would be better if you are under the care of a physician or a naturopath who is familiar with that. With alpha lipoic acid you also have to be aware that you can lower your blood sugar levels so that's another a thing you have to watch out for. 

Linda Elsegood: Something we were talking about before. How important is diet?

Dr John Kim: You know, I think that there is again a very romantic idea that you take LDN and it's like a magic bullet. It works for everything. I think that diet is important because of the way that that LDN works. You know, in my own practice, what

I do when I take in patients with autoimmune diseases, in the beginning, I just say eat well, and patients would not listen, and the minority wouldn’t.  So now I just do the full food allergy testing because that way, I can see, and show them, and then lead them to not eat these groups of food.

And second, we need to do allergy drops to normalize your response to that food because obviously it's not killing off our population, but I also would say that there's something that has changed, that our people are having autoimmune diseases. It’s like an epidemic. You know this is everywhere. Everyone is having an autoimmune condition. Why is that? I think it has to do with we're doing something different. Has our genetics changed in 50 years? I don't think so. What has changed? Our diet has changed, and our pollutant exposure has changed. So, I think that we will find more than a lot of the plastic exposures they were having, we’re going to find to be harmful to our immune system.

I think that research is just beginning on that, but diet I think, is important. Why? Because everything that happens in our body biochemically is predicated by what we eat, what we put in our body. Then if we eat anti-inflammatory food then our body will become anti-inflammatory. If we eat pro-inflammatory food then the end result is that we will be suffering from the high levels of inflammation in the body. So, I think that LDN is a wonderful tool: however, it does not give you permission to eat badly every day, smoke, and pursue an unhealthy lifestyle.

Linda Elsegood: We've just had a question come in, and it says ‘could you define allergy drops?’

Dr John Kim: So allergy drop is basically, I think that everyone has heard of allergy shots. When you have a severe allergy you give shots to people. It does work, but  I just don't like giving shots. My family members hate shots, patients hate shots.

So, what I've done, is looking for a solution that doesn't involve all shooting allergies. It makes sense to me that if it works by giving shots, it will make sense using the GI system because a big portion of our immune system is in our gut anyway. So, I've been looking for a solution to this problem for about five years. I found a solution.

I'm told that this is the more common approach in Europe to the use of allergy drops and allergy drop means that you, whatever your allergy, whether you're allergic to food or environment, you can create an antigen dose that corresponds to how much you're allergic to.

So, if you're allergic to huge levels, then you give them a minute amount of allergen, and then you systematically teach the immune system by exposure not to overreact. So, you can do that to peanuts, you can do that to wheat., you can do that to milk, you can do that for grass, fungus; the big thing that I see is yeast.

So that's the allergy drops that I talk about. I think that as I said, LDN and immunotherapy go hand in hand in my opinion, for autoimmune, and the reason is very simple; both of them are the intelligent approach to re-educating the immune system. And it seems the immune system is amazing because, that one patient I talked about that she was allergic to the fruit, what I found out was that she was allergic to grass. And grass, of course, is the cousin of fruit. So, I treated her grass allergy for about a year, and low and behold, she was able to eat fruits again, and I never went to even specific foods. I just treated grass, because that was the one thing that she was most allergic to.

So, it shows how intelligent immune system is. Of course, she was also taking LDN at the same time, which I think shortened the duration needed for her to go into remission.

Linda Elsegood: Well, I'd actually like to now talk about your LDN book that you've just managed to get published, and it's available on Amazon.

Could you tell us more about your book?

Dr John Kim: Yes, you know, it kind of began as my notes, because in the beginning, LDN was like magic. It would work. It would work. And I was almost thinking, why does it work? Why does it work? So, I started reading, and first, it was blogged on your website.

And then I just dug deeper, because of my research background I just went to the research databases and I would just read different studies, and understand better how low dose naltrexone would work. And of course, there are books already available. I think you were the editor in one of those books, but I wanted to go to the source and learn more.

And so this book is called LDN primer, and I call it primer because I feel like even after 15 years of using low dose naltrexone, I'm still a beginner. And in here I just talk about the history of LDN, and LDN as a noble anti-inflammatory agent for our central nervous system, which I don't think is utilized very often outside my clinic.

And then LDN for treating endorphin deficiency syndrome. Again, I'm looking at the conditions that LDN can treat as groups, so if you have an inflammatory condition for the central nervous system, LDN can be useful, even though it's not an autoimmune condition. LDN can be useful for people who have endorphin deficiency, and who knows if the bipolar disorder, depression, anxiety are a subset of endorphin deficiency syndrome, and I certainly treat it that way, and I have utilized LDN alongside an SSRI with great effect. And even a bipolar disorder with great effect. And then the other thing is LDN as Immuno adaptogen, and then I talk about atypical uses of LDN.

And then the last chapter I talk about clinical considerations of using LDN and share stories of my patients and my observations and ideas that I had, like dosing, you know, and how the dosing is determined. It's not scientific. It's been just supposition. I was just guessing. So then means we have the right to ask.

And what's really wonderful about your Facebook group is the interactiveness, and I see what they mean because some of the people start 0.5 and they think that's too much. I had to cut to 0.1 because.

Like in my practice, that's what I do. I look at a person and try to determine how much endorphin reserve do they have in their life.

If someone has high functionality, then I don't mind starting off 1.5 and then rapidly branch up, going up to 4.5. But if I get the sense that they are very depleted, I would start at 0.1 and then march slowly to get them to 4.5, but take my time doing it and looking for any side effects. So it's been a result of me wanting to understand LDN better and starting a blog and just continued writing.

And I kind of got caught in the web of interestingness of LDN, and I just couldn't stop writing and stop researching. And even preparing for this show, I found out there are more studies out now, and it's really a fascinating subject.

Linda Elsegood: I know a lot of people want to know how do they know how high to go if 4.5 isn't the sealing. How do they know that the dose is right for them?

Dr John Kim: Yeah. So, I think that again, understanding how LDN works is crucial. So, I call it two different dosings. One dosing is linear dosing, the other dosing is synergy dosing. So what do I mean by that? The synergy dosing; I'm referring to the LDN educating the immune system to calm down. So for most autoimmune diseases, I utilize LDN; the lowest amount of LDN required to put a patient into remission, or their symptoms into zero. So, in those cases, some patients are taking 0.5. if they're in remission. I don't want to increase it, because if their disease comes back, then I want to have a little bit of room left over to increase the dosing.

But if there are other people who have central nervous system issues, so I'll give you an example of what I mean by this. Neuropathy would be a great peripheral neuropathy. Diabetic neuropathy would be a great example. Or another example would be post-herpetic neuralgia, and LDN can do amazing things, but in those settings, we are not really counting on the LDN to reset the immune system, we’re using LDN as conventional medication, as an agent to create an anti-inflammatory effect in the central nervous system. And for that, I think that 1.5 to 4.5 dosing is a bit limited, and you have to look for ways to either make LDN work harder and then bring out the LDN synergy, and my to-go tool for that is acupuncture, especially the neuroanatomical approach to acupuncture seems to go very well with LDN. Another tool that I use routinely is alpha-lipoic acid. It seems it can enter the central nervous system with ease and works very well in synergy with LDN.

Linda Elsegood: I'm going to have to stop you there, John. We'll have to have you back on another show. And we really appreciate you being here with us today.

Dr John Kim: Thank you.

Belmar Pharmacy is a nationally respected compounding pharmacy. They compound low dose naltrexone, LDN bio-identical hormones. And accustom amino acids and mineral blends. They're based in Colorado and ship nationwide. Their goal is better patient outcomes through quality compounding, combining effective communication between practitioner, pharmacist, and patient.

Call +1 800-525-9473 or visit Belmarpharmacy.com.

Linda Elsegood:  Any questions or comments you may have, please Contact Us.  I look forward to hearing from you. Thank you for joining us today. We really appreciated your company. Until next time, stay safe and keep well.

Terry from the US shares her experience of LDN for Graves Disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Terry from the United States shares his Graves Disease and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.

Terry was diagnosed with Graves Disease in 1984, around the time that her father passed away. The stress triggered an unproportionate thyroid response leading to a prolonged period of fatigue and weight loss.

She was 45 years old at the time, and her symptoms impacted upon her ability to sleep, exercise and socialise with friends and family. 

After learning about Low Dose Naltrexone (LDN) through one of her daughter’s friends, Terry’s health has improved exponentially. She no longer suffers from extreme fatigue and is much happier than ever before.

This is a summary of Terry’s interview. Please listen to the rest of Terry’s story by clicking on the video above.

Bev uses LDN for Graves, Psoriasis and Psoriatic Arthritis - 12th August (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Bev from Israel shares her Graves Disease and Psoriasis and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.

Bev has lived across the world in South Africa and Australia, but it wasn’t until she returned to Israel that she began to experience her symptoms of Grave’s disease. This coincided with her pregnancy, leading to an enormous amount of stress on Bev’s body.

Combined with the usual symptoms of pregnancy, Bev then began to suffer from blurred vision and lost a lot of weight rapidly. Concerned about the health of her unborn child, Bev was determined to find a solution.

Thankfully bev was able to give birth to a healthy baby girl, but her symptoms still progressed afterwards. She reached a point where she described herself as a “walking skeleton”, but fortunately had come across Low Dose Naltrexone (LDN) after researching it thoroughly.

Once starting on LDN, Bev has never looked back. She no longer has severe headaches in the evening and is now back to “nearly 100%”. She recommends LDN to anyone who’s even remotely interested.

This is a summary of Bev’s interview. Please listen to the rest of Bev’s story by clicking on the video above.

Dawn Ipsen, PharmD - 4th Dec 2019 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today I'd like to welcome my guest pharmacist, Dr Dawn Ipsen, who is not only the owner of one compounding pharmacy but two confounding pharmacies in Washington State.  Thank you for joining me today, Dawn.

Dawn Ipsen: [00:01:35] Well, thank you Linda so much for having me. It's an absolute pleasure.

Linda Elsegood: [00:01:39] Great. So tell us, we're all interested. What made you decide you wanted to be a pharmacist?

Dawn Ipsen: [00:01:47] Oh, yes. So I knew at a, pretty early on that I wanted to be in healthcare on some aspect and pharmacy was very intriguing to me and started on that path and lucky for me, I got an opportunity to be a compounding pharmacy intern while I was in pharmacy school in a compounding pharmacy and immediately fell in love.

And so that was my path. I loved how personalized it was, how unique it was, how I was doing things that none of my classmates and colleagues was doing and so that started my journey. This was in the Seattle area. I went to the University of Washington School of pharmacy, and it was almost 20 years ago now and got my doctor and pharmacy degree there, and I've enjoyed it thoroughly.

Linda Elsegood: [00:02:43] So how did you get from pharmacy school to owning to compounding pharmacies?

Dawn Ipsen: [00:02:50] So I've always been an entrepreneur and really loved business sides of things and kind of had this long term goal that someday I was going to own a pharmacy and it definitely happened earlier in my career than I expected.

I had been working for the Kusler's family at Kusler's compounding pharmacy and had always told them: "When you're ready to do something else, keep me in mind." And got that call. Became owner of Kusler's compounding pharmacy. And  Linda, that was almost six years ago now and was just minding my own business, running my pharmacy, helping my community, doing great work.

And a couple of years into that, I received a call from another owner, the owner of Clark's compounding pharmacy in Bellevue, and he was looking for a buyer. He wanted to retire and he'd done his research and determined that he thought I would be a good fit, that I did the kind of pharmacy work that he liked to do, and I help people the way that he felt was the best way.

And so I've owned now Clark's compounding pharmacy in Bellevue, Washington for three years and even the pharmacies are only 25 miles apart. They kind of do similar, but yet different things or both, compounding, online pharmacies, Sterile. Kusler's does contract with some insurance plans, so we do help patients with that.

And Clark's is licensed in nine states, so we work with patients and not only Washington state, but Oregon, Idaho,  Arizona and Nevada. And we have Colorado and a couple of other States as well. So that's been really wonderful, great, fun and challenging. And it's just really neat that I get to use my really strong chemistry and biology background and help people really solve medication problems, for people and pets.

We helped the whole family. So that's intriguing and fun.

Linda Elsegood: [00:04:59] Wow. We never know.  It is been three years. You might get another phone call from another pharmacy.

Dawn Ipsen: [00:05:07] You never know. However, my staff might call crazy people if I do that, but no, I enjoy it, and I love the challenge and I think that it's something that, we're really successful at. We pride ourselves in the quality and in our teamwork and how we take care of patients and that we treat our patients like their family, and how we would want our family to be treated and very personalized with that care.

Linda Elsegood: [00:05:36] So with all your compounding, what forms do you compound LDN into?

Dawn Ipsen: [00:05:44]  So Low Dose Naltrexone is expanding. Actually had been working with Odell style Trek zone for roughly 10 years now, and kind of decided to become a state expert Low Dose Naltrexone about five years ago. And back then it was very primarily capsules only, and that's what we saw and actually five, 10 years ago it was even the doses were very structured at certain doses, not a lot of variability to it.   And we've learned so much, right?  Over the research and over the years. Now we're doing a much wider array of doses. Everything from ultra-low or micro-dosing for maybe patients who

are on pain therapies already and need some extra help with their immune system to even much higher doses, more frequent doses for mood situations or post-traumatic stress or depression.  And along with that, we're also helping patients who maybe there's an autism spectrum situation going on and they don't want to or aren't willing to take capsules in which we're able to make flavoured liquids and we're able to do now LDN in a transdermal.

And a transdermal is very different than just a topical. This is a cream-based that's very special and it's designed to drive the drug into the body,  but it's a great way to go when you have a patient who won't participate or can't participate in taking an oral medicine. And on top of it, we've started doing a lot of topical LDN treatment for skin conditions specifically for  psoriasis, eczema, things of that nature. So those are primarily the most dosage forms we see. So different ways to do oral, different way to do a transdermal, and then we have the topicals as well.

Linda Elsegood: [00:08:03] If I could just ask you, the topical cream or lotion, what do you call it?

Dawn Ispen: [00:08:11] It's usually a topical cream for the skin dermatology conditions.

Linda Elsegood: [00:08:17] So if you've got eczema or allergies or psoriasis and the other skin conditions like backtracked syndrome, Haley Haley's disease, applying that directly to the skin, what do you see? Does it take away the itchy, flaky redness? What do you see when people use it?

Dawn Ispen: [00:08:45] Definitely, so what we were noticing is, in psoriasis patients that were just on oral low dose naltrexone that they would typically get to effect at some point.  But it took a very, very long time. And it was, as you can imagine, hard for patients to be patient, so to speak, and wait for that. Because I mean, we all know how miserable it is to have skin that's irritated. It's red, it itches, it burns, it stings, all those things. It's very difficult to have any sort of quality of life. So we started doing both. We would help doctors with the normal oral therapies that we would be used to seeing, but then we would start making a customized cream for them, naltrexone being one of the ingredients. And we would put it in a cream base that actually had nutraceutical components to it that would help calm the skin already on its own with no drug in it. So yes, they often risked with the naltrexone and that cream base would find relief of redness and inflammation, and we'd start seeing the healing of autoimmune skin disorders much faster than if they were doing the oral alone.

On top of that, we could work more closely meeting their direct needs. So if it was causing pain, we could add an ingredient to help with that. If it was a histamine reaction, we could add another ingredient to help with that. And so it gave us a lot more flexibility to be very, very specific and customized with the treatment they needed on the skin that was bothering them.

Linda Elsegood: [00:10:31] So my question would be, Dawn. If, for example, 3 mg, the highest dose that you could tolerate orally and you're putting a topical lotion or cream on, does it matter how much naltrexone is in that cream? Does it get absorbed into the system? How does it work? Do you see what I'm saying? If three is all you can take and you've got three in the cream, does it matter?

Dawn Ispen: [00:11:03] Well, it depends. So if we are doing the topical cream base, there's a slim chance you could have some added absorption, but then we may want to go back and talk about what does it mean they couldn't tolerate more than three? Was it directly affecting their stomach and they were having nausea or cramps or something like that?

Or was it affecting sleep or why was it three their oral stealing number, right?  So when we go topical or even transdermal, a lot of times we can go higher than one would have thought than they could do orally and still avoid the side effects because they're avoiding that, what we call it in pharmacy, the first-pass effect. When a drug is swallowed it goes to the stomach and then it goes to the liver, and that's sometimes the portion of the system that's causing the side effect. And if we're avoiding that, we can get away with that. The other thing is that, given in these dermatology conditions, if we're doing Naltrexone  and it is just topical, we're not getting the systemic absorption that we would be getting in oral or transdermal delivery.

So in that sense, the amount probably doesn't quite matter, but also the amount of drug that's in that cream, they could put quite a bit on and not be getting a significant dose directly into the bloodstream. 

Linda Elsegood: [00:12:34] okay. And then would it be exactly the same as oral LDN and that if it kicks into the bloodstream, it would be the, and then go quite quickly.

Dawn Ispen: [00:12:44] Righ, so if it did go into the bloodstream or it was a transdermal delivery, what was driven in intentionally, you would expect to get the same effect as if they were on oral. You may avoid side effects of the stomach directly because again, you're not putting that drug directly in their stomach, and that can be helpful for some patients for sure.

Linda Elsegood: [00:13:09] okay. Now, patient feedback. What has been the outcomes of your patients taking LDN?

Dawn Ispen: [00:13:21] The feedback has been very, very positive. It definitely seems to be a drug that Is extremely safely tolerated with very few side effects, if any, and if there are side effects, they're typically dose-related and things that can be managed by proper titrations and proper dosing.

The benefit can be anywhere from subtle improvement to very profound improvement with a huge direct link to a much better quality of life. Even on my more subtle improved patients, they often find that their improvement was way more than they anticipated because they'll sometimes take a vacation or a holiday from LDN and realized symptoms are coming back.

They are not feeling as good,  more fatigued, on and on. And then when they restart low dose naltrexone they can then more clearly see how much benefit it was providing to them.

Linda Elsegood: [00:14:23] And what conditions would you say patients are taking LDN for? Do you know that?

Dawn Ispen: [00:14:30] Yeah. I often do know that. Of course, we have our longterm patients that have been on it for five, even five-plus years at this point that had the Fibromyalgia, Multiple Sclerosis, Crohn's disease, of course. We're seeing even more though conditions that are just in general inflammation-based and in which we're trying to control the body's autoimmune system. So Hashimoto's and Graves', Lyme disease, Rheumatoid Arthritis. We have patients that are using it, as I mentioned, for psoriasis specifically. And then, more recently in the last couple of years, we're seeing patients who do have post-traumatic stress disorder or depression that is been not responding to normal therapies and even cancer conditions that have been very helped by low dose naltrexone.

Linda Elsegood: [00:15:30] So do any of your doctors around your area prescribe LDN for infertility issues?

Dawn Ispen: [00:15:41] We don't have too many in our area that is doing naltrexone for infertility. However. there ts definitely known, it's definitely talked about. There's pretty good literature on its use  and it just might be that I'm not right next to where the infertility clinics are that are working with that.

Linda Elsegood: [00:16:09] What about mental health issues?

Dawn Ispen: [00:16:13] Yes, we definitely have doctors who are using this for mental health issues and are really trying great because they're trying to bring to light the whole topic of mental health and how important it is. And they become so much more open to other ways of thinking, other treatments, other modalities for these patients. So we're seeing things like the use of ketamine for depression. We're seeing the naltrexone being used for depression and PTSD. And I mean, I can honestly say that had patients who had been very concerned about their wellbeing and that once they work with these types of providers, down the road, their quality is just so much better and they're doing great with it.

Linda Elsegood: [00:17:02]  And of course, so many mental health issues with antidepressants, etc can make people feel a bit sluggish, drowsy whether naltrexone actually makes you feel brighter and better, and it's not addictive either.

Dawn Ispen: [00:17:24] Right. You get that endorphin release, which is so important to our wellbeing and how we feel in our motivation and our willingness and desire to interact with others in our community and those are all such important things for being part of this world.

Linda Elsegood: [00:17:45] Do you have any patient case studies you could share with us?

Dawn Ispen: [00:17:49] I'm sure. A couple of my favourites is one, she's a younger patient. Actually, she's only in her 20s, and she comes into the pharmacy and she's been coming in a long time getting naltrexone. At this point, it's usually just a quick pickup: " Hey, how are you?" And out the door, we go. And I was at the counter with her and I literally had to stop and scratch my head and I couldn't.  She looked just so great, so normal, so just young and vibrant. And I honestly couldn't remember why she even has started low dose naltrexone. And so I asked her. I was like, can you remind me why do you take the naltrexone?

What is it doing for you? And, and she's actually multiple sclerosis patients, which we actually have a lot of in Washington state because where we're located in our sunlight exposure and vitamin D levels and all that. And it has hot her completely in remission with her vitamin D and other things she's doing as well.

But she looks just so normal.  Is the only way I can describe it. And how cool is that? They here we have a twenty-something who, who is able to be a vibrant member of the community and have a well-rounded life and do what she wants to do. So she's one of my favourites because thank goodness you're staying on it to help slow any progression of the disease process that might occur later on.

And then I do have one psoriasis patient that I've ever seen psoriasis-like this before. She actually had it even on the back of her calves, which is an unusual location. And started naltrexone. Did that for about a month, just the naltrexone orally itself. And then when we added in the cream.

And when she would come back for refills, I just couldn't get over it, how fast it was healing and we marked it.  I actually took pictures of when she first picked up and then when she came in for refills and then now there's nothing left. So it's been really awesome to see somebody who had been dealing with this for most of her life, who now is doing great, well-controlled.

Her immune system is just functioning properly.

Linda Elsegood: [00:20:05] How long did that take before her skin looked normal again?

Dawn Ispen: [00:20:12] Yeah. So skin is always slow. I mean, that's with patience is a virtue. It's on any skin condition as you have to allow for the full all derm cycle, which usually is right about six weeks on average.

And so, you start in with treatment knew at the beginning or just trying to get the treatments on board and help with any symptom relief they might need. And then usually, like in this particular case, it was really about at the three-month mark that she was coming in happy that the condition was starting to reverse and go back to how the skin was supposed to be.

And then of course for full healing, it's another month or two after that. And then he'd go into maintenance mode at that point.

Linda Elsegood: [00:21:00] Well, that's amazing, isn't it? I mean, psoriasis, if you have it, and I know somebody with psoriasis, how embarrassing it is. People look at you when it's really bad. I'm not comfortable either, is it? So something that can heal and clear that up It's amazing.

Dawn Ispen: [00:21:26] Yeah, it's wonderful because it can be, like you said, not only visibly unappealing and they will often try to hide it if they can with clothing and coverage, but it hurts, it clot cracks, it bleeds, it burns, it itches.

It's just horribly uncomfortable and unrelenting, you know, it doesn't just stop. It continues.

Linda Elsegood: [00:21:50]  Do you have many children as patients?

Dawn Ispen: [00:21:53] We do. We actually work with some doctors who are very in touch with the pediatric population and that's their speciality. And they use naltrexone usually in the kids that they have some sort of a spectrum disorder where they're noncommunicative and they aren't interacting as we hoped they would be able to.

They're a great population to work with and that's where we get to become very creative and work really closely with the family itself on determining how does this child want to receive its medication and is it as simple as custom dosing and maybe they want the capsule a certain colour because it might be more appealing visually to them. Fine, perfectly great with that. Or do they need a liquid and do they want it to be flavoured a certain way or do they need a lozenge? And then for the most difficult of patients, we can do the transdermal cream delivery that I even have a couple of families that they actually apply it to the child's back, back skin area at night when the child is sleeping. So they can receive their dose that way. 

Linda Elsegood: [00:23:25] Wow. So what else do you know about LDN that you haven't shared with us?

Dawn Ispen: [00:23:35] With LDN there are lots of things can augment the therapy of LDN and getting the most out of it. And it's really looking at the patient at a whole and trying to discover what ways can we reduce inflammation load in that patient's body along with optimizing the dosage form and the regimen, the strength and the timing, it should be taken.

 I do work a lot on talking with patients about the importance, especially in Washington,  of vitamin D,  the importance of good gut health and probiotics. We're working more with patients on using full-spectrum C-- to help with pain and anxiety as well,  antioxidants and organic diet and how important all of these things are to get inflammation loads down, to get the best effect out of it.

Linda Elsegood: [00:24:32] Yes. Diet is a big one, isn't it? People do notice a big difference by changing their diet.

Dawn Ispen: [00:24:42] Diet is so huge, and you know, us living in a suburban area, gardening and farming is not simple, right? And our seasons make that challenging too, and just really encouraging our community to buy from the farmer's market get organic as much as you can, grow your food when you can yourself and just eat well, take care of your body, you're worth it. You know? It's like you are worth the extra effort in doing that.

Linda Elsegood: [00:25:14] And sugar is another big thing, isn't it? If you can't cut it out, at least cut it down.

Dawn Ispen: [00:25:21]  Right, and look for good alternatives that are natural and if you do have to have that sweet because, you're right, it's in everything and it's hidden often it's hard to even know it's there.

Linda Elsegood: [00:25:36] It surprises me when you look at a tin food.  Dugar is in pipe beans, it's in..Just trying to think of something else. It's gone. Slipped my mind. But...

Dawn Ispen: [00:25:52] Ketchup, salad dressings.

Linda Elsegood: [00:25:55] Exactly. Sugar, sugar, sugar, sugar. It's not easy, but it's, it's similar if you're buying foods and you read the labels, gluten is in so many things.

Dawn Ispen: [00:26:13] Absolutely.

Linda Elsegood: [00:26:14] I mean, when I first started to be gluten-free, it took me ages to do my shopping because I was looking at everything and trying very hard not to get anything with gluten in it.

But it becomes easier because you know which things you can have and which things you can't have. Once you've gone through reading everything, it does become easier and you do find alternative things. I use honey as a sweetener and I use coconut sugar but it's brown colour so I can still make cakes and waffles occasionally, but there isn't a different colour but if you close your eyes you don't know, you can't see that it's a different colour. You can be creative. It's very expensive to eat organic here, and I should think it's pretty similar in the US isn't it?

Dawn Ispen: [00:27:18] It is. It definitely can be challenging to be able to do that and hard for some families to make that happen. And I always like to refer to the dirty dozen as they call it, of if you really have to pick and choose which product is most important to purchasing, organic versus maybe you could save the finances on something else.  That's at a nice way to integrate or ended up the pathway. Lucky for us in our area, at least, we do have a substantial number of farmer's markets that are all close by and available different days of the week but that can be an option for patients that are really trying to do those things, but maybe not able to get it from the grocery store all the time.

Linda Elsegood: [00:28:16] And the thing is, with organic food, it doesn't last as long as a non-organic without us being sprayed with things to keep it fresh longer.

Dawn Ispen: [00:28:28] And it sometimes doesn't look as pretty, does it either? There are more bruises and changes in how it grows and things like that.

But it's funny how our minds have that used to be the normal, right? That produce always looked like that. And then we've changed to think that that product should look perfect in every instance and that's not necessarily the case. It comes back to what you're saying with the sugar.

Linda Elsegood: [00:28:59] We have a supermarket here that sells half-price vegetables from the supplier, and they're all packaged and they're called wonky vegetables. So the carrots, parsnips, that probably got deformed but they're perfectly fine. There's nothing wrong with them. It's just as they call them wonky,  they're not perfect and I think that's great.

Linda Elsegood: [00:29:34] We've come to the end of the show so we could have carried on talking for ages. We'll have you back again another time and until then, stay well and we will speak to you again soon.

Dawn Ispen: [00:29:48] Wonderful. Thank you. Have a great day.

Linda Elsegood: [00:29:50] Thank you. Bye-bye. This show is sponsored by Kusler's compounding pharmacy and Clark's compounding pharmacy. They are more than a drug store. They are highly trained, compounding pharmacy experts, combining the art and science of preparing personalized medications to meet your specific needs, improving lives by solving medication problems for people and pets, creating solutions to medication challenges.

Visit www.kuslerspharmacy.net

Any questions or comments you may have, please email us at Contact@ldnresearchtrust.org.  I look forward to hearing from you. Thank you for joining us today. We really appreciated your company. Until next time, stay safe and keep well.

Russell - 29th May 2019 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today, my guest is Russell from the United States who takes LDN for hypothyroidism, Graves' disease, a non-Hodgkin's lymphoma.

Thank you for joining us today, Russell.

Russell: Hi, Linda. It's a pleasure to be speaking with you 

Linda Elsegood: So could you tell us, when did you first notice there was something wrong? How long ago was that?

Russell: So first for me, it was with the non-Hodgkin's lymphoma. The cancer was back in 2016. Um, well that's when I got diagnosed, but I, I had a, uh, a lump on my arm near my elbow and, um, I had seen a lot of, uh, or I saw my primary care physician for it.

And I'm fairly young. I'm 29. Just turned 29. Actually. You know, a couple of weeks ago in February 1st and uh, so, you know, no one thought that it was cancer at the time, as I call it. It's a rare chance that it could be, but you won't know until you get it taken out or get a biopsy or anything like that.

At the time, I was busy working and. Uh, I kind of, you know, drug my feet a little bit to actually get, get it, uh, you know, get the imaging studies that were requested, you know, those types of things done, you know, just being busy with work. So it turned out to be about, uh, it's about 14 months later when I actually got diagnosed and, um, and I, that's when I got the cancer diagnosis and non-Hodgkin's lymphoma.

It's a. Caught 'em anaplastic large cell lymphoma and it's a T cell lymphoma, and it's highly aggressive, and it's, it's, you know, they diagnose it as systemic cause I had a lymph node and, um, it can end up anywhere and everywhere in the body very quickly. And, uh, you know, by the grace of God, at that time, I was diagnosed with stage one.

So that was surgically removed, and I'm kind of taking a step back. So that was surgically removed. That's how I actually found out what was. And so then they referred me to an oncologist. And, uh, so I saw an oncologist and, um, you know, they recommended to chemotherapy. So I did the chemotherapy first-line therapy, 

And, um, so that, so that, and then in that context, it was an adjuvant therapy. From what I understand. Based on the terminology, because you know, I had pet scans, CT scans done, you know, after that biopsy. And there was no other detectable disease at the time. So it was stage one, and they said, Oh, since this is stage one, and you know, we think we, uh, you know, can, you know, take care of this with the first-line therapy.

And it was like they said, a 90% chance of longterm, durable remission or cure with chemotherapy. Then ten months later. Um, I, uh, started to get skin lesions that were just popping up. And I'm saying that now cause I know what they are now, but at the time they just look like, like little bumps and um, you know, they started on the legs and arms and they'd get on the back and had some on the face and not a whole lot on my face, but mostly on the, you know, the limbs and trunk and stuff like that as a body.

And it's like, what should go in and get this checked out? So I had told my oncologist about it, and he saw some of them, and he's like, Oh, this is kinda, you know, it looks, you know, it doesn't look like anything cancer-related, but then we'll recommend you to the, you know, the lymphoma, dermatology, ontological specialists.

So, and that was kind of a little, what am I seeing? This guy where I'm in? This doesn't look like him, but they just want to make sure. So I saw him. And, um, you know, he's used to seeing these types of things. And you know, it was kind of shocking to me when I saw his face because he was puzzled. He was kind of like, or not puzzled, I should say, but he was concerned that this was cancer.

And so I did some biopsies there, and they started checking lymph nodes, and they found the lymph node and the growing. And I was like, Oh, we need you to go, you know, and get this a lymph node biopsy as well. So those biopsy results came back. So it came back as a recurrence for the primary, uh, lymphoma that large anaplastic cell in the groin.

And then I had metastasis to my skin and with that, of that same primary lymphoma, then there was one of the other skin biopsies that were done. It was suspicious for. Another type of skin lymphoma called mycosis fun goatees. But they were kind of going back and forth cause it kind of looked like the primary, um, anaplastic large cell lymphoma and this other type.

So then the recommendations, you know, back for all those fines reflected and met my primary colleges. Again, I was like, well, we have the second-line therapy. We still believe it is a high chance. To, uh, to cure this. And those were the terms they used. And, um, so I went through that, and I did four rounds of a targeted drug.

It's called an upper and Tufts and bad. So my client will make antibody. And, um, within two cycles, I got another emission. All the skin lesions, you know, went down at the lymph nodes in the groin were gone. And then, um, the oncologist said, well, in order for us to cure you, we need to get you into, um, high dose chemotherapy with the STEM cell transplant.

So this is not just the normal chemo. I mean, this is like, you know, high dose. They give you enough chemo where they wipe out everything that's in your bone marrow, and they rescue you with a STEM cell transplant. So. Uh, so I was like, you know, at the big, you know, kind of against that, because I looked into a lot of, uh, you know, the side effects and longterm stuff is associated with that.

And there's just a lot of risks with me being young. And I, I was never in favour of doing that. And, um, so my plan then was after I got through a mission, you know, which the mission was done about that, maybe the second cycle. And so I did two more additional. Then after that, my plan was to try to, you know, pursue some holistic type treatment and, um, to, to sort of try to keep it away or whatsoever.

But, you know, look, uh, shortly after that, maybe two to three weeks after I was done with that chemo, I started to get skin lesions again. So, I mean, that kind of shocked me as well. That was pretty quick. I was like, Holy cow. Um, you know, I just got off of the chemotherapy, so I went back in and got some more biopsies, and sure enough, it was the same, you know, stuff in my skin again, this with this lymphoma.

I was like, well, now it's insight, you know, it came back so rapidly. They were like, well, you know, if you don't go into this, you know, high dose chemotherapy with the STEM cell trust that we wouldn't expect, you know, Chris, your condition and with relapse and stuff like that to live past six months.

So that was kind of, I was like, Oh, wow. Yeah. So then, you know, this was, that was in January of 2018 so, I mean, I was, I wasn't convinced that that was gonna cure me because the data that they supply for me, um, you know, the bone marrow transplant team and my primary oncologist, I mean, the data was showing a 30% chance of survival for three years.

You know, and they were saying that secure. I mean, I, and, and I was trying to be objective as possible. And I mean, it just didn't pan out to me. I mean, I have a three-year-old, and I'm thinking to myself, it's like, well, how is this going to cure me? You know, there's no data showing ten years, 20 years, or 30 years.

But I don't know. That's what they told me. And that's what the data said. So that's when I decided to, um, you know, not pursue any more conventional therapy, you know. So I stepped outside of the standard of care, and I went to a, uh, a clinic down in Mexico, ships the hospital, and I got some, um, you know, uh, treatment down there and some natural therapies and some immune therapy, um, called Cooley's toxins.

And this is how we're just starting to get him to the point where, um, I started my LDN. So after, you know, all those treatments and stuff I did down there. Actually, I responded pretty well. Um, you know, a lot of the skin lesions, I had probably about 95% of those was gone when I came back home though, right before I left Mexico.

Um, they had tested, uh, just normal thyroid panel testing and my T, um, TSH was like really, really low. It was like, I think it was like 0.05, and so then I got back here, I got the results, and they sent it to me an email, and I saw my functional medicine doctor, and he was like, Whoa, this looks like graves' disease.

So I'm like, Oh my gosh, you're, this is, you know, I've got another condition. You know, trying to deal with cancer and, and, um, so he did some more tests and some thyroid antibody tests and TSI, those tests like that. And, um, my TSI came back. It was elevated positive for graves' disease. So then that's when he had recommended for me to take, um, LDN low dose naltrexone.

So I started taking that, and he started me off at 1.5 milligrams, and the plan was to escalate that dose over a, you know, go up 1.5 milligrams every two weeks. But what I found is that I wasn't able to do that initially. I mean, I somewhat explain that a little bit. I went from, I think it was what, 1.5 to three and in two weeks, and I tried to go.

Oh to 4.5 then the next weekend, I did have some side effects. I was like, Whoa. I had to, I just felt so exhausted the next day, and you know, really, you know, really tired and fatigue, muscle aches and stuff like that. So I, you know, took a step back and I went back to three. And, uh, took that for a little bit longer than asked my doctor, you know, if it would be okay if I just went to force.

I did that for probably a couple of weeks then. Then I finally went to the 4.5, and that's where I'm at now, taking, taking that every night at bedtime. And, um, some of the side effects that I've experienced. Um. I mean, this is very low. And that's one of the things I like about LDN. There are very low side effects, but I did call sleep services for me in the beginning, and every once in awhile I'll have an issue where I'll find myself, you know, awakened and, um, you know, two or three o'clock in the morning or something like that.

But I started, um, taking some magnesium. With that, because that's been shown to help with sleep and stuff like that. So that's, that's actually been helping me quite a bit here, uh, over the last couple of months. And, uh, so I've been taking it, so I, I haven't, I mentioned when I first started it, I started it back in, uh, was in April of 2018?

So I'm coming up to about a year and, uh, on the LDN. But other than that, I think those were all the side effects that I experienced. And one other, uh, interesting. Um, synergy I think I experienced with LDN because I'm, I'm doing this, this holistic protocol, Gerson therapy, those two different types of therapies for just the maintenance and to keep cancer from coming back.

And I'll kind of, um, I'm not jumping over the place here, but I'll kind of come back to the cancer part a little bit too because I believe it's helping there as well. But, um, yeah. So all the therapies I mentioned, I was doing this Coleys talks and this immunotherapy, so mixed bacterial vaccines, non-infectious, and this is a dead bacteria, but I won't go too much into the details or the history behind that, but it's a very old, um, you know, Dr. William Coley was the father considered the father, you know, therapy. And he actually formulates, came up with the formulation for this mixed bacterial vaccine and found out that, uh. What he, what he saw is that a, a patient that, uh, had sarcoma and of the, I think it was a bone sarcoma, and this patient was not supposed to survive this disease.

And he actually, you know, coldly found him alive and well, you know, long after he was supposed to be gone. And he, uh. They looked into the records and found out what actually happened to him. But this man was breaking out into high fevers and chills and, you know, shake. So he had this, uh, uh, air syphilis infection and, and, you know, dr Coley believed that that caused the tumour regression, and he, you know,

A scientist actually tried to reproduce that, and he was able to do that by infecting people with live bacteria. But he killed a lot of people. And this is doc, well documented in the medical literature, you know, would dr Kohli and his results. But, uh, so then he actually, you know, you can't kill people giving them something to treat a condition.

So he actually, uh, you know, thought that, Hey, what if I heat-killed this bacteria and gave it to people? And, you know, he didn't cause any mortality associated with it, but he did have, uh, some tumour regression. And um. But anyway, so that's a little bit of history behind this vaccine, but there's some literature out there that shows that LDN has the potential to, um, help the maturation of dendritic cells and, you know, Coleys this vaccine actually.

Um, it, it works through your dendritic cells. And, and, um, from my experience when I started taking LDN and continuing my, uh. Immunotherapy vaccine, I notice more the reactions from the vaccine were more intensify. And, uh, and it, that didn't happen before. Like, actually I responded better. Like, one of the metrics for this vaccine is it does cause you to have high fevers.

And, you know, I, I, I didn't really get them consistently and, um, but once I started, you know, using LDN and the vaccine, I mean, it actually. You know, I would get getting consistent, you know, high fevers in some record temperatures and stuff like that. But, um, so I thought that was pretty interesting. So my, all my doctors were kind of on board with me using that.

So I was working with my doctor. I just wasn't, you know, doing experiments and stuff like that by myself. But, um, so kind of, uh, I think that's the gist of. With the, with, with the vaccine, but back to, um, with Gray's disease, as I mentioned, I started taking it in April of last year, and about three months after that, um, in July, I had more thyroid testing done and my graves' disease would, it's remission, you know, just in those three months of taking LDN.

So that was pretty, I was pretty sold on using it. And, uh, as I said, I still use it to this day, so, and, and, um, but my, so regarding cancer, um, so like I said, I've been taking it and, um, you know, also for cancer, but in doing all these other things, but. You know, as I mentioned that my doctor mentioned in January of last year that I wasn't expected to live past six months without that high dose chemotherapy and STEM cell transplant.

And so now I'm actually, you know, it's almost a, it would be going on like 13 months since that, um, prognosis and I had a pet scan back in September of last year, and that actually showed that I didn't have any, you know. Evidence of any tumours or anything like that. So was a clear pet scan.

Linda Elsegood: Yeah. That's amazing.

Russell: So, um, so I'm, uh, you know, and I believe that LDN has helped as well. You know, as I said, especially with the vaccine and, you know, and, uh, so I'm, I am, you know, going to continue to take that and. And, um, and another thing that's pretty interesting that from that I came across is, you know, there's a lot of talks now about cancer STEM cells and circulating tumour cells.

And, you know, the literature is saying that this is what causes a person to relapse. And, you know, what I found highly interesting is, um. No. From some of dr his work and, and some of the, uh, the information that's out there regarding some of the people that he gave LDN after they had, you know, successful cancer treatment.

You know, even if it was conventional or whatsoever surgery, and that people tended not to relapse after taking LDN. And the connection here, and this is some of the conclusions that I've been drawing just from some of the research that I've been doing, but I'm coming out of a university of Michigan, dr max, which I mean, they have one of the leading STEM cell cancer STEM cell research laboratories, and they're kind of leading building this.

But one of the. Cytokines and these are just inflammatory cytokines. It's called interleukin six is what causes these cancer STEM cells to go into the proliferation cycle. And that's kind of what they found from their, their research and the connection with LDN is I've seen some of the data that they looked at some of these cytokines that LDN effects.

And, and this is in particular, I believe you probably though the doctor, I think you've, I've heard you interviewed him, he did some clinical trials with fibromyalgia

Linda Elsegood: Jarred Younger

Russell: Yeah. That, yes, that's his name there. And, uh, one of the tops of the, uh, on the top of that list, my memory serves me correctly, I believe it was to where necrosis factor out was, which is another, you know, uh, typical transcription factor or a cytokine.

I forget. Specifically, but interleukin six is like the second one on that list. So LDN, um, inhibits that. So I meant, I know, as I said, these are some of the conclusions I'm drawing from my research. But, so, I mean, maybe that's by one of the mechanisms by which, you know, LDN may keep a person in remission.

And, uh, so, and I, I've heard a couple of testimonials of people. You know, having, you know, in remission from cancer, especially if LDN, you know, bought them, but that person in remission, you know, and they stopped taking it and have a relapse again. And there's a guy, I believe, I think his name is Kevin. I think he had liver cast.

And I believe you interviewed him and he mentioned the head in an interview, uh, with you regarding, uh, the, the, you know, after he stopped taking ODN and liver cancer came back, I believe his name, Kevin, but, um. But anyway, so I just thought that was interesting in some other, you know, functional medicine doctors have kind of reported some of the similar, um, similar, you know, things happen.

Linda Elsegood: well, you know, it's totally amazing, and I'm sure people find you an absolute inspiration. Definitely.

Russell: Yeah. So, uh, yeah, I'm just very, yeah, I've been blessed in it, you know, I thank God for. You know, everything and you know, the success I'm having, and you know, being in good health right now. And so that's a

Linda Elsegood: yes.

Well, long may you continue in the way in which you are and lead a normal, healthy, happy life.

Russell: Yes.

Linda Elsegood: Thank you, Russell.

Russell: Okay, great, great. And uh, you had the great day and thank you for all that you do. And uh, that's great. 

Linda Elsegood: This show is sponsored by our members who made donations. We'd like to give them a very big thank you.

We have to cover the monthly costs of the radio station software and with phone lines and phone calls to be able to continue with their idea of the show. And thank you for listening.


Any questions or comments you may have, please Contact Us.  I look forward to hearing from you. Thank you for joining us today. We really appreciated your company. Until next time, stay safe and keep well.